phenylephrine hci

Generic: phenylephrine hci

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name phenylephrine hci
Generic Name phenylephrine hci
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

phenylephrine hydrochloride 10 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1249
Product ID 51662-1249_120030fe-4ccd-f689-e063-6294a90a4bfb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA203826
Listing Expiration 2026-12-31
Marketing Start 2018-09-16

Pharmacologic Class

Classes
adrenergic alpha1-agonists [moa] alpha-1 adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621249
Hyphenated Format 51662-1249

Supplemental Identifiers

RxCUI
1666372
UNII
04JA59TNSJ

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name phenylephrine hci (source: ndc)
Generic Name phenylephrine hci (source: ndc)
Application Number NDA203826 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 1 mL in 1 VIAL, SINGLE-DOSE (51662-1249-1)
  • 25 POUCH in 1 CASE (51662-1249-3) / 1 mL in 1 POUCH (51662-1249-2)
source: ndc

Packages (2)

51662-1249-1 1 mL in 1 VIAL, SINGLE-DOSE (51662-1249-1) 51662-1249-3 25 POUCH in 1 CASE (51662-1249-3) / 1 mL in 1 POUCH (51662-1249-2)

Ingredients (1)

phenylephrine hydrochloride (10 mg/mL)

Linked Drug Pages (1)

PHENYLEPHRINE HCI ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "120030fe-4ccd-f689-e063-6294a90a4bfb", "openfda": {"unii": ["04JA59TNSJ"], "rxcui": ["1666372"], "spl_set_id": ["7602fb73-3ce3-5978-e053-2991aa0abea3"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 mL in 1 VIAL, SINGLE-DOSE (51662-1249-1)", "package_ndc": "51662-1249-1", "marketing_start_date": "20180916"}, {"sample": false, "description": "25 POUCH in 1 CASE (51662-1249-3)  / 1 mL in 1 POUCH (51662-1249-2)", "package_ndc": "51662-1249-3", "marketing_start_date": "20200429"}], "brand_name": "PHENYLEPHRINE HCI", "product_id": "51662-1249_120030fe-4ccd-f689-e063-6294a90a4bfb", "dosage_form": "INJECTION", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "51662-1249", "generic_name": "PHENYLEPHRINE HCI", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PHENYLEPHRINE HCI", "active_ingredients": [{"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "10 mg/mL"}], "application_number": "NDA203826", "marketing_category": "NDA", "marketing_start_date": "20180916", "listing_expiration_date": "20261231"}